Stay updated on Pembrolizumab Combo with Chemo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo with Chemo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo with Chemo in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page with the HTML header indicating access is blocked, replacing the previously loaded study record content and navigation.
    Difference
    18%
    Check dated 2026-09-20T19:54:01.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now includes a MedlinePlus Genetics related topics section listing Lung cancer and related topics, linking to genetic information about the disease.
    Difference
    0.1%
    Check dated 2026-09-13T21:55:57.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page’s related topics section, including links to Lung cancer and MedlinePlus Genetics, was removed, reducing cross-references to related content.
    Difference
    0.1%
    Check dated 2026-09-06T18:51:48.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page adds a funding note for the 2017 U.S. NIH Grant/Contract and includes Lung cancer as a related topic under MedlinePlus Genetics, along with a revision tag update from v3.6.5 to v3.6.6.
    Difference
    0.2%
    Check dated 2026-08-30T16:05:31.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, representing a new build of the site. No study content or user-facing details were changed.
    Difference
    0.0%
    Check dated 2026-08-09T08:18:24.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    - The Lung cancer, related topics:, and MedlinePlus Genetics sections/links were removed from the page, reducing access to related informational resources linked from the study record. - This narrows the page content to focus on the trial details and primary study information.
    Difference
    0.1%
    Check dated 2026-08-01T19:56:39.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo with Chemo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo with Chemo in NSCLC Clinical Trial page.